Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Researchers at Karolinska Institutet have identified biomarkers in the blood associated with symptoms of long COVID, particularly severe respiratory disorders. The discovery could pave the way for ...

“It is medically inaccurate to group all symptoms lasting more than 12 weeks — such as headache, anosmia, or dyspnea — under one broad diagnosis ... Elling supported the study’s approach. “Systematic ...

At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or school.

People who suffered from mucormycosis and recovered continue to battle long-term health effects of the fungal infection, such ...

With a new grant from the American Diabetes Association, Raphael Fraser, PhD, will study how glucose monitoring could enhance diabetes prevention.

ICMR study reveals long-term health effects of mucormycosis, urging focus on treatment and rehabilitation for survivors.

People who have survived cancer as children are at higher risk of developing severe COVID-19, even decades after their ...

A newly distinguished University of New Mexico professor discusses her clinical research and advocacy around Long COVID.

More than five years have passed since a global pandemic was declared, but COVID-19 remains ever-present. However, more ...

Long-term health risks linked to childhood cancer may increase the chances of severe COVID-19 in adulthood, even decades ...

In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and miraculously beating the odds.